Biologic Responses to the Interface Between Device and Circulation

[1]  P Litwak,et al.  In vivo evaluations of a new thromboresistant polyurethane for artificial heart blood pumps. , 1988, The Journal of thoracic and cardiovascular surgery.

[2]  Arnan Mitchell,et al.  A shear gradient–dependent platelet aggregation mechanism drives thrombus formation , 2009, Nature Medicine.

[3]  Hui-hua Li,et al.  Better anticoagulation control improves survival after valve replacement. , 2002, The Journal of thoracic and cardiovascular surgery.

[4]  J F Antaki,et al.  Fluid dynamic characterization of operating conditions for continuous flow blood pumps. , 1999, ASAIO journal.

[5]  Mitsuo Umezu,et al.  Effects of Turbulent Stresses upon Mechanical Hemolysis: Experimental and Computational Analysis , 2004, ASAIO journal.

[6]  M C Oz,et al.  Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. , 1995, The Annals of thoracic surgery.

[7]  J F Antaki,et al.  Computational flow optimization of rotary blood pump components. , 1995, Artificial organs.

[8]  W. Wagner,et al.  Blood biocompatibility analysis in the setting of ventricular assist devices , 2000, Journal of biomaterials science. Polymer edition.

[9]  M. Oz,et al.  The continuing evolution of mechanical ventricular assistance. , 1997, Current problems in surgery.

[10]  James F. Antaki,et al.  A design improvement strategy for axial blood pumps using computational fluid dynamics. , 1996, ASAIO journal.

[11]  M. Gorbet,et al.  What really is blood compatibility? , 2000, Journal of biomaterials science. Polymer edition.

[12]  Roland Hetzer,et al.  Pathophysiologic role of contact activation in bleeding followed by thromboembolic complications after implantation of a ventricular assist device. , 1995, ASAIO journal.

[13]  S. Wisniewski,et al.  Measurement of hemostatic indexes in conjunction with transcranial doppler sonography in patients with ventricular assist devices. , 1999, Stroke.

[14]  S. Diamond,et al.  Systems biology to predict blood function , 2009, Journal of thrombosis and haemostasis : JTH.

[15]  Guy Ts.  Evolution and current status of the total artificial heart: the search continues. , 1998 .

[16]  D. Goldstein,et al.  Worldwide Experience With the MicroMed DeBakey Ventricular Assist Device® as a Bridge to Transplantation , 2003, Circulation.

[17]  A. Hoffman,et al.  Application of radiation-grafted hydrogels as blood-contacting biomaterials , 1983 .

[18]  Gary An,et al.  Translational Systems Biology of Inflammation , 2008, PLoS Comput. Biol..

[19]  Jeongho Kim,et al.  PediaFlow™ Maglev Ventricular Assist Device: A Prescriptive Design Approach , 2010, Cardiovascular engineering.

[20]  V. Deneer,et al.  Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. , 2010, JAMA.

[21]  B. Reichart,et al.  Platelet activation markers in patients with heart assist device. , 2005, Artificial organs.

[22]  O H Frazier,et al.  Surgery for Acquired Cardiovascular Disease Initial experience with the AbioCor Implantable Replacement Heart System , 2004 .

[23]  Christopher Bowles,et al.  Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. , 2007, The Journal of thoracic and cardiovascular surgery.

[24]  Kenji Yamazaki,et al.  Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: coating comparison and platelet activation. , 2007, Journal of biomedical materials research. Part A.

[25]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[26]  J. Antaki,et al.  An extended convection diffusion model for red blood cell-enhanced transport of thrombocytes and leukocytes , 2009, Physics in medicine and biology.

[27]  H. Scheld,et al.  Analysis of platelet function during left ventricular support with the Incor and Excor system. , 2004, The heart surgery forum.

[28]  L. Magder,et al.  Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices. , 2007, Interactive cardiovascular and thoracic surgery.

[29]  M. Sefton,et al.  Flow cytometric analysis of material-induced platelet activation in a canine model: elevated microparticle levels and reduced platelet life span. , 1997, Journal of biomedical materials research.

[30]  M. Slaughter,et al.  Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. , 2007, The Journal of thoracic and cardiovascular surgery.

[31]  S. Baldwin,et al.  Coagulation on biomaterials in flowing blood: some theoretical considerations. , 1997, Biomaterials.

[32]  James F. Antaki,et al.  Computational Simulation of Platelet Deposition and Activation: I. Model Development and Properties , 1999, Annals of Biomedical Engineering.

[33]  James W Long,et al.  Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. , 2005, Congestive heart failure.

[34]  K. Ishihara,et al.  Modification of polysulfone with phospholipid polymer for improvement of the blood compatibility. Part 1. Surface characterization. , 1999, Biomaterials.

[35]  Steven Deutsch,et al.  EXPERIMENTAL FLUID MECHANICS OF PULSATILE ARTIFICIAL BLOOD PUMPS , 2006 .

[36]  L. Vroman,et al.  Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids , 1962, Nature.

[37]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[38]  G. Stein,et al.  Properties of blood‐contacting surfaces of clinically implanted cardiac assist devices: Gene expression, matrix composition, and ultrastructural characterization of cellular linings , 1995, Journal of cellular biochemistry.

[39]  Andrew Boyle,et al.  Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. , 2008, The Annals of thoracic surgery.

[40]  S. Deutsch,et al.  Fluid dynamic analysis of the 50 cc Penn State artificial heart under physiological operating conditions using particle image velocimetry. , 2004, Journal of biomechanical engineering.

[41]  E. Topol,et al.  The case for routine genotyping in dual-antiplatelet therapy. , 2010, Journal of the American College of Cardiology.

[42]  A. Shuldiner,et al.  Genotyping: one piece of the puzzle to personalize antiplatelet therapy. , 2010, Journal of the American College of Cardiology.

[43]  O. Frazier,et al.  Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. , 1993, Texas Heart Institute journal.

[44]  H. Kitano.  Systems Biology: A Brief Overview , 2002, Science.

[45]  L. Gamble,et al.  Covalent surface modification of a titanium alloy with a phosphorylcholine-containing copolymer for reduced thrombogenicity in cardiovascular devices. , 2009, Journal of biomedical materials research. Part A.

[46]  M. Sefton,et al.  Platelet activation in whole blood by artificial surfaces: identification of platelet-derived microparticles and activated platelet binding to leukocytes as material-induced activation events. , 1995, The Journal of laboratory and clinical medicine.

[47]  P. McCarthy,et al.  Hemostatic profiles of HeartMate ventricular assist device recipients. , 1995, ASAIO journal.

[48]  M. Acker,et al.  181: Early Neurological Adverse Events (NAE) after Pulsatile VAD Implantation in 455 Patients: Incidence, Severity and Outcome , 2009 .

[49]  K. B. Chandran,et al.  Towards Non-thrombogenic Performance of Blood Recirculating Devices , 2010, Annals of Biomedical Engineering.

[50]  V. Roger,et al.  The incidence of ischemic stroke in chronic heart failure: a meta-analysis. , 2007, Journal of cardiac failure.

[51]  J. Connell,et al.  Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS). , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[52]  M C Oz,et al.  Implantable left ventricular assist devices. , 1998, The New England journal of medicine.

[53]  M. Oz,et al.  Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. , 1996, The Journal of thoracic and cardiovascular surgery.

[54]  J. P. Black,et al.  Does surface chemistry affect thrombogenicity of surface modified polymers? , 2001, Journal of biomedical materials research.

[55]  W. Wagner,et al.  Assessing acute platelet adhesion on opaque metallic and polymeric biomaterials with fiber optic microscopy. , 2000, Journal of biomedical materials research.

[56]  K. Ishihara,et al.  Surface modification of a titanium alloy with a phospholipid polymer prepared by a plasma-induced grafting technique to improve surface thromboresistance. , 2009, Colloids and surfaces. B, Biointerfaces.

[57]  Kenneth A. Solen,et al.  Computational Model of Device-Induced Thrombosis and Thromboembolism , 2005, Annals of Biomedical Engineering.

[58]  M C Oz,et al.  Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. , 1996, The Annals of thoracic surgery.

[59]  Brian Savage,et al.  Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor , 1996, Cell.

[60]  J F Antaki,et al.  Computational fluid dynamics as a development tool for rotary blood pumps. , 2001, Artificial organs.

[61]  S. Etoch,et al.  Current status of the AbioCor implantable replacement heart. , 2001, The Annals of thoracic surgery.

[62]  Mehdi Behbahani,et al.  A review of computational fluid dynamics analysis of blood pumps , 2009, European Journal of Applied Mathematics.

[63]  Dong-Choon Sin,et al.  Surface coatings for ventricular assist devices , 2009, Expert review of medical devices.

[64]  Javed Butler,et al.  Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. , 2007, Journal of the American College of Cardiology.

[65]  David Kaye,et al.  A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[66]  H. Baumgartner,et al.  Measurements of platelet interaction with components of the vessel wall in flowing blood. , 1989, Methods in enzymology.

[67]  T. Lindahl,et al.  Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces. , 2004, Biomaterials.

[68]  D. Zimpfer,et al.  Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation. , 2008, Artificial organs.

[69]  J D Hellums,et al.  Red blood cell damage by shear stress. , 1972, Biophysical journal.

[70]  V. Jeevanandam,et al.  Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. , 1996, Circulation.

[71]  W. Wagner,et al.  Monocyte tissue factor expression and ongoing complement generation in ventricular assist device patients. , 1998, The Annals of thoracic surgery.

[72]  G. Lowe.  Virchow’s Triad Revisited: Abnormal Flow , 2003, Pathophysiology of Haemostasis and Thrombosis.

[73]  Shmuel Einav,et al.  Device Thrombogenicity Emulator (DTE)--design optimization methodology for cardiovascular devices: a study in two bileaflet MHV designs. , 2010, Journal of biomechanics.

[74]  Michael V Sefton,et al.  Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. , 2004, Biomaterials.

[75]  T. Mussivand.  Neurological dysfunction associated with mechanical circulatory support: complications that still need attention. , 2008, Artificial organs.

[76]  B. Meyns,et al.  Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants. , 2007, Artificial organs.

[77]  K. Ishihara,et al.  Modification of polysulfone with phospholipid polymer for improvement of the blood compatibility. Part 2. Protein adsorption and platelet adhesion. , 1999, Biomaterials.

[78]  Kyung Hyun Ahn,et al.  Parametric study of blade tip clearance, flow rate, and impeller speed on blood damage in rotary blood pump. , 2009, Artificial organs.

[79]  Shaun P Jackson,et al.  The growing complexity of platelet aggregation. , 2007, Blood.

[80]  T. Mussivand.  Mechanical circulatory support devices: is it time to focus on the complications, instead of building another new pump? , 2007, Artificial organs.

[81]  Leonid Goubergrits,et al.  Numerical modeling of blood damage: current status, challenges and future prospects , 2006, Expert review of medical devices.

[82]  W. Kop,et al.  Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices , 2009, Nature Clinical Practice Cardiovascular Medicine.

[83]  R. Hetzer,et al.  Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow MicroMed DeBakey LVAD. , 2000, The Annals of thoracic surgery.

[84]  Anita Tierney,et al.  Neurological Events During Long-Term Mechanical Circulatory Support for Heart Failure: The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Experience , 2004, Circulation.